What is the appropriate workup and management for a lesion on the lower eyelid (under the eye)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Management of Lower Eyelid Lesions

For a lesion on the lower eyelid (under the eye), you must first determine whether it is benign or malignant through clinical examination and biopsy when indicated, as this fundamentally determines management—benign lesions can often be observed or excised for cosmetic reasons, while malignant lesions require complete oncologic excision with margin control.

Initial Clinical Assessment

Examine the lesion for specific features that suggest malignancy versus benign pathology:

Red Flags for Malignancy

  • Nodular mass with ulceration 1
  • Extensive scarring or localized crusting 1
  • Lash loss in the affected area 1
  • Yellow conjunctival nodules with intense inflammation (suggests sebaceous carcinoma) 1
  • Chronic, unilateral, unresponsive inflammation 1
  • Recurrent chalazia in the same location 1

Specific Malignant Presentations

  • Sebaceous carcinoma: May appear as chronic unilateral blepharitis/conjunctivitis that doesn't respond to treatment, particularly in elderly patients 1, 2
  • Squamous cell carcinoma: Irregular, ulcerated lesion with potential for local invasion 3
  • Basal cell carcinoma: Most common malignant eyelid tumor 1

Benign Lesion Features

  • Molluscum contagiosum: Shiny, dome-shaped umbilicated lesion(s) on eyelid skin or margin 2
  • Nevus: Most frequent benign histologic diagnosis (57.1% in one series) 4
  • Vascular lesions: Can present as swelling mimicking other pathology 5

Workup Algorithm

Step 1: Clinical Examination

  • Document lesion size, location, color, and characteristics
  • Check for eyelash involvement and meibomian gland changes
  • Assess for conjunctival involvement or extension
  • Palpate for preauricular lymphadenopathy (suggests malignancy with metastatic potential)

Step 2: Determine Need for Biopsy

Biopsy is mandatory if:

  • Any features suggesting malignancy are present
  • Lesion is atypical or unresponsive to conservative treatment
  • Diagnosis is uncertain 6, 7

Important: Even clinically benign-appearing lesions can be malignant mimics (e.g., discoid lupus mimicking squamous cell carcinoma) 6, so maintain a low threshold for biopsy.

Step 3: Imaging (Selective)

  • NOT needed for simple benign lesions confined to the eyelid 8
  • High-resolution MRI with and without contrast is indicated for:
    • Suspected orbital or periorbital involvement
    • Extensive facial involvement
    • Plexiform neurofibromas 8

Management Based on Diagnosis

Benign Lesions

Molluscum Contagiosum 2:

  • Treatment options: incision and curettage (aggressive enough to cause bleeding), simple excision, excision with cautery, or cryotherapy
  • Identify and treat all nascent lesions to reduce recurrence
  • Conjunctivitis may take weeks to resolve after lesion removal
  • Follow-up only if conjunctivitis persists
  • Caveat: Large/multiple lesions in adults suggest immunocompromised state—consider HIV testing

Cosmetic Excision of Benign Margin Lesions 4:

  • Posterior lamellar wedge resection through infraciliary incision provides excellent cosmetic outcomes
  • Appropriate for lesions up to 8 mm
  • Achieves 76.2% excellent and 23.8% good cosmetic results
  • Mean patient satisfaction score: 96/100

Malignant Lesions

Sebaceous Carcinoma 9, 2:

  • Excision by a surgeon experienced in eyelid tumors is mandatory
  • Use adjunctive therapy for residual pagetoid component
  • Discuss specimen handling with pathologist BEFORE biopsy
  • High risk for multicentric origin and pagetoid spread

Squamous Cell Carcinoma 3:

  • Wide excision with histological margin control (minimum 9 mm clearance documented in successful cases)
  • Immediate reconstruction (e.g., Mustardé rotation flap for defects 30×15 mm)
  • Verify no lymphovascular, perineural, or deep structure invasion on pathology
  • Sentinel node biopsy may reveal early metastatic disease 10

Basal Cell Carcinoma 10:

  • Mohs surgery or complete surgical excision with frozen-section margin control offers lowest recurrence rates
  • This is the consensus preferred method

Ocular Surface Squamous Neoplasia 9, 2:

  • Treatment options:
    • Local excision with cryotherapy to edges AND/OR
    • Topical chemotherapeutic agents (mitomycin-C or fluorouracil)
    • Some studies show topical chemotherapeutics alone may achieve complete resolution
  • Management by experienced specialist
  • Use anterior segment OCT for diagnosis and follow-up monitoring

Critical Pitfalls to Avoid

  1. Don't dismiss chronic unilateral blepharitis in elderly patients—this is a classic presentation of sebaceous carcinoma 1

  2. Don't assume clinically benign appearance excludes malignancy—histopathological confirmation is essential for atypical lesions 6, 7

  3. Don't perform inadequate excision of malignant lesions—margin control is critical for preventing recurrence 10, 3

  4. Don't forget to assess for immunocompromised state when seeing extensive molluscum lesions in adults 2

  5. For suspected sebaceous carcinoma, coordinate with pathologist BEFORE biopsy to ensure proper specimen handling 9, 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.